Results from the KM of DSS analysis suggested that increased SASH3 expression was correlated with adverse DSS in ESCC, LGG, and UVM; lowly expressed SASH3 was associated with shorter OS in CESC, HNSC, LUAD, SARC, SKCM, and UCEC (Figures 3A–C). The gene discussed is SASH3; the disease is esophageal squamous cell carcinoma.